XJZY obtained the domestic production drug registration certificate for estradiol tablets
According to the Zhitong Finance APP, XJZY announced that the company recently received the "Drug Registration Certificate" for estradiol tablets approved and issued by the National Medical Products Administration. The company's estradiol tablets have been approved for registration. The indications for estradiol tablets are for diseases related to estrogen deficiency and can also be used to prevent osteoporosis
According to the Zhitong Finance APP, XJZY (002332.SZ) announced that the company recently received the "Drug Registration Certificate" approved and issued by the National Medical Products Administration for estradiol tablets, which have been approved for registration. The indications for estradiol tablets are for diseases related to estrogen deficiency and can also be used to prevent osteoporosis
